Abstract
Magnetic nanoparticles have been proposed for biomedical applications for several years. Various research groups worldwide have focused on improving their synthesis, their characterization techniques and the specific tailoring of their properties. Yet, it is the recent, impressive advances in nanotechnology and biotechnology which caused the breakthrough in their successful application in biomedicine. This paper aims at reviewing some current biomedical applications of magnetic nanoparticles as well as some recent patents in this field. Special emphasis is placed on i) hyperthermia, ii) therapeutics iii) diagnostics. Future prospects are also discussed.
Keywords: Magnetic nanoparticles, biomedicine, drug delivery, hyperthermia, disease detection, therapy, cancer diagnostics, targeted therapeutics, magnetic imaging
Recent Patents on Nanotechnology
Title: Recent Progress in Biomedical Applications of Magnetic Nanoparticles
Volume: 4 Issue: 2
Author(s): Ioanna Giouroudi and Jurgen Kosel
Affiliation:
Keywords: Magnetic nanoparticles, biomedicine, drug delivery, hyperthermia, disease detection, therapy, cancer diagnostics, targeted therapeutics, magnetic imaging
Abstract: Magnetic nanoparticles have been proposed for biomedical applications for several years. Various research groups worldwide have focused on improving their synthesis, their characterization techniques and the specific tailoring of their properties. Yet, it is the recent, impressive advances in nanotechnology and biotechnology which caused the breakthrough in their successful application in biomedicine. This paper aims at reviewing some current biomedical applications of magnetic nanoparticles as well as some recent patents in this field. Special emphasis is placed on i) hyperthermia, ii) therapeutics iii) diagnostics. Future prospects are also discussed.
Export Options
About this article
Cite this article as:
Giouroudi Ioanna and Kosel Jurgen, Recent Progress in Biomedical Applications of Magnetic Nanoparticles, Recent Patents on Nanotechnology 2010; 4 (2) . https://dx.doi.org/10.2174/187221010791208795
DOI https://dx.doi.org/10.2174/187221010791208795 |
Print ISSN 1872-2105 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4020 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Image Fusion of Diagnostic Ultrasound with Other Modalities
Current Medical Imaging Autophagy: Molecular Mechanisms and their Implications for Anticancer Therapies
Current Cancer Drug Targets Microenvironment and Brain Tumor Stem Cell Maintenance: Impact of the Niche
Anti-Cancer Agents in Medicinal Chemistry Cyclic ADP-ribose (cADPR) and Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP): Novel Regulators of Ca 2+-Signaling and Cell Function
Current Molecular Medicine The Membrane-targeted Alkylphosphocholine Erufosine Interferes with Survival Signals from the Extracellular Matrix
Anti-Cancer Agents in Medicinal Chemistry Mechanisms of Tumor Cell Necrosis
Current Pharmaceutical Design Targeting Protein-Protein and Protein-Nucleic Acid Interactions for Anti-HIV Therapy
Current Pharmaceutical Design Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Protective Role of Natural Products in Glioblastoma Multiforme: A Focus on Nitric Oxide Pathway
Current Medicinal Chemistry Targeting Opioid and Neurokinin-1 Receptors to Treat Alcoholism
Current Medicinal Chemistry Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy
Current Cancer Drug Targets P-Glycoprotein and Breast Cancer Resistance Protein Affect Disposition of Tandutinib, A Tyrosine Kinase Inhibitor
Drug Metabolism Letters The Mechanism of Action of Salsolinol in Brain: Implications in Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Radiopharmaceuticals for Oncology Drug Development: A Pharmaceutical Industry Perspective
Current Pharmaceutical Design Bacteria and Bacterial Toxins as Therapeutic Agents for Solid Tumors
Current Cancer Drug Targets Diagnostic and Therapeutic Applications of Recombinant Antibodies:Targeting the Extra-Domain B of Fibronectin, A Marker of Tumor Angiogenesis
Current Pharmaceutical Design Caffeine Effect on HIFs/VEGF Pathway in Human Glioblastoma Cells Exposed to Hypoxia
Anti-Cancer Agents in Medicinal Chemistry Activatable Optical Probes for the Detection of Enzymes
Current Organic Synthesis Editorial (Personalized Medicine in the Age of Pharmacoproteomics: A Close up on India and Need for Social Science Engagement for Responsible Innovation in Post-Proteomic Biology)
Current Pharmacogenomics and Personalized Medicine Ultrasound-Mediated Cancer Therapeutics Delivery using Micelles and Liposomes: A Review
Recent Patents on Anti-Cancer Drug Discovery